COMP <GO>
HCTI vs MSFT // GROSS PROFIT MARGIN
Healthcare Triangle Inc. (NASDAQ) VS. Microsoft Corporation (NASDAQ) • 15-METRIC TALLY: HCTI 2
— MSFT 8
▲ GROSS PROFIT MARGIN LEADER: HCTI
LAST: $6.30 (-2.02%) • MKT CAP: $5.6M
gross-margins
96.00%
LAST: $530.14 (-0.16%) • MKT CAP: $3.94T
gross-margins
67.66%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HCTI VS. MSFT)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | HCTI | MSFT | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | 96.00% | 67.66% | +28.34 | HCTI | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 26.54% | -61.54 | MSFT | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 19.9x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | 1.55% | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | 47.10% | -107.10 | MSFT | /operating-margins <GO> |
| Net Profit Margin | -60.00% | 41.17% | -101.17 | MSFT | /net-margins <GO> |
| Revenue Growth (YoY) | 18.80% | 17.91% | +0.89 | HCTI | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.70% | -0.70 | MSFT | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | 9.35 | -9.15 | MSFT | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 6/9 | -3.00 | MSFT | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 5.74% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 24.9 | 64.8 | -39.86 | MSFT | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.14 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 24.2x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.6M | $3.94T | -$3.94T | MSFT | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | HCTI REV | MSFT REV | HCTI GROSS % | MSFT GROSS % | HCTI FCF | MSFT FCF |
|---|---|---|---|---|---|---|
| FY 2026 | — | $331.84B | — | 67.9% | — | $66.99B |
| FY 2025 | $13.9M | $281.72B | 98.0% | 68.8% | -$16.5M | $71.61B |
| FY 2024 | $11.7M | $245.12B | 98.0% | 69.8% | -$1.1M | $74.07B |
| FY 2023 | $33.2M | $211.91B | — | 68.9% | -$2.2M | $59.48B |
| FY 2022 | — | $198.27B | — | 68.4% | — | $65.15B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HCTI // BETA —
MSFT // BETA 1.14